Gregg Morin

Researcher
  • BC Cancer Research Institute
  • University of British Columbia
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • All Cancers

    Implementing a pan-Canadian standardized mass spectrometry-based proteomics approach for the analysis of clinical cancer samples: validation using archived breast cancer specimens for biomarker discovery

    If your body were a factory line, DNA would be the blueprint, containing all the instructions needed to build and maintain it. Downstream you would find RNA, which acts as the factory supervisor, tak...

    Read More
  • Blood Cancers

    Strategies to divert malignant potentials in acute leukemia

    Understanding acute leukemia is like trying to solve a complex puzzle. The DNA sequence of our cells forms the puzzle pieces, but these pieces can change their appearance – and alter the overall...

    Read More
  • Rare Cancers

    New vistas on cancer biology and treatment: conceptual advancements from the forme fruste project

    A team of Vancouver-based scientists is set to continue its groundbreaking research into rare tumours after receiving renewal funding from the Terry Fox Research Institute. The team led by Dr. David H...

    Read More
  • Pediatric & Young Adult Cancers

    Precision oncology for young people (PROFYLE)

    For the first time in Canadian history, more than 30 pediatric cancer research and funding organizations have joined forces through Terry Fox PROFYLE, a pan-Canadian project to give children, adolesce...

    Read More
  • Completed
    Rare Cancers

    Genomics of forme fruste tumours: new vistas on cancer biology and treatment

    Studying “rare and unusual” forme fruste tumours may not seem like the most obvious way to advance cancer research, but pathologist Dr. David Huntsman’s work is revolutionizing the w...

    Read More

Related News & Events

  • TFRI News|November 12, 2024

    Eight pan-Canadian research teams receive newly created TFRI-MOHCCN Technology Development Awards

    New joint funding initiative from TFRI and the MOHCCN will support the deployment of novel technologies to accelerate precision medicine for cancer.

  • Research Highlight|August 31, 2020

    New treatment possibilities for young women diagnosed with rare form of ovarian cancer

    A recent finding by TFRI-funded researchers in BC may offer a new treatment possibility for people diagnosed with a rare and aggressive form of ovaria...

  • All News & Events